Use a portable medical cooler with ice packs or cold gel packs rated to maintain 28C for the duration of transport
Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN et al (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
Tirzepatide is approximately two years into widespread availability (approved 2022-2023), making it newer than semaglutide but mature enough that millions of patient-months of real-world safety and efficacy data now exist
Patients will see the most progressive weight loss a few months into treatment
The messaging here is so wrong coming from an athlete like her and very dangerous for society, commented a third person
Why treatment fit matters Weight loss pills arent a magic fix for menopause